<p>Masimo (NASDAQ:MASI) will release its quarterly earnings report on Thursday, 2026-02-26. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Masimo to report an <strong>earnings per share</strong> (EPS) of $1.49.</p>
<p>The market awaits Masimo's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.12, which was followed by a 4.61% drop in the share price the next day.</p>
<p>Here's a look at Masimo's past performance and the resulting price change:</p>
<p></p><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">1.20</td>
<td align="right">1.23</td>
<td align="right">1.21</td>
<td align="right">1.42</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">1.32</td>
<td align="right">1.33</td>
<td align="right">1.36</td>
<td align="right">1.80</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">-5.00</td>
<td align="right">-12.00</td>
<td align="right">-7.00</td>
<td align="right">12.00</td>
</tr>
</tbody>
</table><p></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772035323_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" width="700" height="500" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772035323_0.png"/></p>

<h3>Stock Performance</h3>
<p>Shares of Masimo were trading at $175.35 as of February 24. Over the last 52-week period, shares are down 5.77%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analyst Observations about Masimo</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Masimo.</p>
<p>Analysts have given Masimo a total of  ratings, with the consensus rating being . The average one-year price target is $, indicating a potential .</p>
<p>To track all earnings releases for Masimo visit their earnings calendar on our site.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>

<p>Masimo (NASDAQ:MASI) is set to release its quarterly earnings report on February 26, 2026, with analysts expecting an EPS of $1.49. The company previously beat EPS estimates by $0.12, but shares dropped 4.61% the following day. Currently trading at $175.35, Masimo's stock is down 5.77% over the past year, raising concerns among long-term investors. Analysts' ratings and price targets will be crucial for market sentiment ahead of the earnings announcement.</p>

benzinga_article

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

iShares Biotechnology ETF

SPDR S&P Health Equip

Masimo

iShares US Medical Devices

Direxion S&P Biotech Bear 3X

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

Uncovering Potential: Masimo's Earnings Preview